Skip to main content
Home
    • ALL Specialities ALL Specialities
    Home
    Home

    Jonathan W. Riess, MD, MS

    Article

    Commentary: Concomitant Therapies May Affect NSCLC Survival, August 2022

    Author:
    Jonathan W. Riess, MD, MS
    Publish date: August 11, 2022
    • Read More

    Article

    Commentary: New Horizons in NSCLC Treatment: Adagrasib, Aumolertinib, and Lorlatinib, July 2022

    Author:
    Jonathan W. Riess, MD, MS
    Publish date: July 1, 2022
    • Read More

    Article

    Commentary: Genetic Components of NSCLC, June 2022

    Author:
    Jonathan W. Riess, MD, MS
    Publish date: June 1, 2022
    • Read More

    Article

    Clinical Edge Journal Scan Commentary: Recent Lung Cancer Trial Results, May 2022

    Author:
    Jonathan W. Riess, MD, MS
    Publish date: May 3, 2022
    • Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties